Press Release

Research and Markets (http://www.researchandmarkets.com/research/de5090/antimigraine_drug) has announced the addition of the "Anti-Migraine Drugs - Global Strategic Business Report" report to their offering.

This report analyzes the US And European markets for Anti-Migraine Drugs in US$ Million.

Annual forecasts are provided for the period 2006 through 2015.

A six-year historic Analysis is also provided for these markets.

The report profiles 53 companies including many key and niche players such as

• Abbott Laboratories Inc.
• Eisai Inc.
• Eisai Inc
• Johnson & Johnson Inc.
• Kowa Pharmaceuticals America Inc.
• MAP Pharmaceuticals Inc.
• Merck & Co.
• Inc.
• Poze
• Poze.
• Winston Pharmaceuticals Inc.
• Wyeth Consumer Healthcare
• Zogenix Inc.
• AstraZeneca Plc
• Bayer AG
• Ethypharm S.A.
• GlaxoSmithKline Plc
• Meda AB
• Novartis AG

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

For more information visit http://www.researchandmarkets.com/research/de5090/antimigraine_drug